A new U.S. guideline covers the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic (CKM) syndrome.CKM syndrome is defined as a health disorder stemming from connections among heart disease, kidney disease, diabetes, and obesity.Healthy lifestyle and weight management are strongly recommended for all patients, and GLP-1 drugs and other medications are also recommended starting in the early course of the condition.
The first dedicated U.S. guideline for cardiovascular-kidney-metabolic (CKM) syndrome makes a big push to unite primary and specialty care in managing large swaths of the population.
The American Heart Association (AHA) and the American College of Cardiology (ACC) now stress interdisciplinary collaboration among cardiologists, endocrinologists, nephrologists, and primary care clinicians caring for patients at various stages of or at risk for CKM syndrome in the new guideline, which was published in the Journal of the American College of Cardiology.
CKM syndrome is defined as a health disorder stemming from connections among heart disease, kidney disease, diabetes, and obesity. Nearly 90% of U.S. adults are said to have at least one CKM syndrome risk factor (e.g., excess weight, high blood pressure, abnormal lipids, high blood glucose, or reduced kidney function).
